- Open Access
Discovery of sensorineural hearing loss and ossicle deformity in a Chinese Li nationality family with spondyloepiphyseal dysplasia congenita caused by p.G504S mutation of COL2A1
BMC Medical Genomics volume 14, Article number: 170 (2021)
Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominant chondrodysplasia characterized by disproportionate short stature, abnormal epiphyses, and flattened vertebral bodies. COL2A1 has been confirmed as the pathogenic gene. Hearing loss represents an infrequent manifestation for 25–30% of patients with SEDC. The characteristics of the hearing impairment were rarely documented.
Audiological, ophthalmic, imaging examinations were conducted on the family members. The whole exome sequencing (WES) was performed to detect the candidate gene, and the Sanger sequencing was used to confirm the causative variation.
COL2A1 c.1510G>A (p.G504S), a hot spot variation, was identified as the disease-causing mutation of the Chinese Li nationality family with SEDC. This variation was co-segregated with the SEDC phenotype in the family and was absent in the 1000 Genomes Project, ESP and ExAC. Clinically, several manifestations were first demonstrated in SEDC patients caused by p.G504S, including sensorineural hearing loss, auditory ossicles deformity, retinal detachment, sacrum cracked and elbow and wrist joints deformity. Other classical SEDC manifestations such as bones and joints pain, midfacial dysplasia, disproportionate short stature, spinal deformity, thoracocyllosis, coxa arthropathy, myopia and waddling gait were also showed in the family patients.
We first identified the mutation p.G504S in COL2A1 gene as the pathogenesis in a Chinese Li nationality family and reported the correlation between p.G504S and atypical clinical phenotypes including sensorineural hearing loss, auditory ossicles deformity, retinal detachment, sacrum cracked and elbow and wrist joints deformity. Our findings would extend the phenotypic spectrum of SEDC and deepen clinicians' understanding of genotype–phenotype correlation of the disease.
Spondyloepiphyseal dysplasia congenita (SEDC, MIM#183900) is an autosomal dominant chondrodysplasia characterized by disproportionate short stature, abnormal epiphyses, and flattened vertebral bodies. With the low incidence of approximately 3.4 per million people, SEDC is a rare clinical subtype of type II collagenopathies. The subtype was firstly reported by Spranger and Wiedemann in 1966.
COL2A1 (OMIM: 120140) has been identified as the pathogenic gene of SEDC, which is located at 12q13.11 with the length of 31,510 bp. It encodes alpha-1(II) chain of type II procollagen, which is composed of 1487 amino acids. Three α-1 chains folded together to form a triple-helix configuration of the procollagen homotrimer. Mature collagen molecules processed through shear, modification and other necessary steps in the extracellular matrix form a covalently cross-linked fibrillar network, providing tensile strength for the connective tissues.
To date, Type II collagenopathies can be classified into at least 16 definite disorders . Among these disorders, SEDC is mainly manifesting spinal deformity. The skeletal system abnormalities show up at birth and worse with age. Other manifestations of SEDC include myopia and/or retinal degeneration detached, cleft palate. Hearing loss represents an infrequent manifestation for 25–30% of patients with SEDC. Most papers reported a loss on the order of 30–70 dB at the higher frequencies (4 to 8 kHz) .
In the present study, a Chinese Li nationality family with SEDC was firstly reported around the world and the COL2A1 p.G504S was identified as the disease-causing mutation. To date, there have been 632 mutations of the COL2A1 reported in the DVD that are pathogenetic and responsible for SED and other subtypes of skeletal dysplasia. (DVD: http://deafnessvariationdatabase.org/gene/COL2A1, 2021.03.12). The mutation p.G504S, as a hot spot, was firstly reported to be associated with sensorineural hearing loss and ossicle deformity in a SEDC family in this study. This finding would extend the phenotypic spectrum of SEDC and deepen clinicians' understanding of genotype–phenotype correlation of the disease. It also laid a foundation of the further study of genetic counselling, fertility guidance and gene function.
The Family 1,908,322, living in Lingshui Li Autonomous County, Hainan province, was a local family that had been passed down for 3 generations. The family members were all of Li nationality. The study was approved by the Committee of Medical Ethics of Chinese People’s Liberation Army (PLA) General Hospital. Written consents were obtained from all the participants aged over 18 and from the next of kin on behalf of the minors/children’s participants. All the experiments in this study were performed in accordance with the Declaration of Helsinki and other relevant guidelines and regulations.
The proband, a 21-year-old deaf-mute female (II3), was admitted to the Department of Otolaryngology-Head and Neck Surgery of Hainan Branch of Chinese PLA General Hospital in July 2019. She underwent detailed inquiry, physical examination and relevant auxiliary examinations in visual, auditory and skeletal systems. 10–20 ml peripheral venous blood samples were taken for DNA extraction and test. Other family members (father, mother, older sister, younger sister and nephew of the proband) (I1, I2, II2, II4, III1) also took part in the experiment and underwent relevant examinations. Their peripheral blood samples were also taken.
Medical history collection and physical examination
Detailed medical history was collected using the standard questionnaire, which included general information, medical history of present illness, past history, personal history, birth history, family history, among others. Physical examination was conducted by a team of experienced specialists and focused on the musculoskeletal, auditory, and visual systems.
Diagnostic audiometer (Madsen Conera, Denmark), headphone with air guide (TDD-39, Denmark) and bone guide (b-71, Denmark), and acoustic conductivity detector (Madsen OTO Flex100, Denmark) were used for pure-tone audiometry (PTA) and acoustic immitance. Instruments were regularly calibrated in accordance with international standards. Audiological tests were conducted in standard soundproof rooms. The average hearing threshold was calculated as the pure tone air-conduction averages of the air-conduction thresholds at 0.5, 1, 2, and 4 kHz. Hearing loss levels were graded into the following categories basis the pure tone air-conduction averages: subtle (16–25 dB), mild (26–40 dB), moderate (41–55 dB HL), moderately severe (56–70 dB HL), severe (71–90 dB HL), and profound (> 91 dB HL).
All the family patients (I2, II2, II3, III1) received spine and hip joint X-ray. The adult patients (I2, II2, II3) also received temporal bone CT scans, PTA, acoustic immitance and ophthalmic tests including optometry, intraocular pressure, anterior segment and fundus colour photography. All the abnormalities evidences of subjects were identified by a team of experienced specialists and technicians.
The whole-exome sequencing (WES) was conducted on DNA samples of the patient II3 and I2 with Illumina HiSeq2500 platform. The target area coverage was 99.73% (II3) or 99.52% (I2). The average sequencing depth for target region was 138.90X (II3) or 180.52X (I2), with 98.72% (II3) or 98.89%(I2) of the target sequence reaching up to 20X. After base identification, raw sequencing reads were mapped against the human reference genome (NCBI37/hg19). Variants were filtered against databases including ClinVar, OMIM and HGMD. Several large-scale population-based databases were also used to eliminate high-frequency variations in the normal population, including EPS6500, 1000 Genomes Project, GnomAD, ExAC, dbscSNV, MatEntScan, dbNSFP. Further bioinformatics analyses were carried out using the SIFT, PolyPhen-2, Mutationtaster, PhyloP and GERP online tools to predict the function of potential pathological variation. Sanger sequencing was performed on DNA samples of other family members to determine whether the potential variation in the candidate gene co-segregated with the phenotype in the family or not. A pair of PCR primers designed to validate the potential causative variation in exon 23 of COL2A1 were as follows: 5′-GAGGATGACATGCGGAAAAGTC-3′, 5′-CAGTTGGATCTTTAGCCCCTCT-3′. All the family members were checked for mitochondrial genome variations associated to hearing loss, including m.1095T>C, m.1494C>T, m.1555A>G, associated with deafness.
The proband (II3) was a 21-year-old deaf-dumb female. At the age of 2 to 3 years, she began to suffer from growth retardation and disproportionate short neck and trunk. At the time of physical examination, she was 125 cm tall and weighed 30 kg. She had bones and joints pain, midfacial dysplasia, barrel chest, kyphoscoliosis, elbow and wrist joints deformity and unsteady waddling gait. History of limb trauma was denied. PTA showed profound hearing impairment in bilateral ears. The spine X-ray indicated that the thoracic spine was curved to the left and the sacrum was cracked. Hip joint X-ray showed significant abnormalities in bilateral hip joints, including aseptic inflammation, subluxation, acetabular fossa shallowing, femoral heads collapsing, articular surface destruction, low-density shadows under the articular surface, unclear boundary, narrowing of joint space, and femoral neck shortening. Temporal bone CT scan revealed that the structure of bilateral auditory ossicles was abnormal with disproportionate short incus bodies. The optometry showed myopia in both eyes. The fundus colour photograph demonstrated abnormalities in fundus tissue, including arc-shaped atrophy spots around the optic papilla, strong white reflection of the nerve fibre layer, stiff macular vascular arch, and yellow-white exudative changes. Intraocular pressure and anterior segment were normal.
The mother of the proband (I2), a 51-years-old female, had short stature since childhood. At the time of physical examination, she was 133 cm tall and weighed 35 kg. She had bones and joints pain, disproportionate short neck and trunk, midfacial dysplasia, kyphosis with limited spinal movement and unsteady waddling gait. PTA showed her bilateral mild high-frequencies hearing loss. The spine X-ray revealed kyphosis. Hip joint X-ray showed aseptic inflammation of bilateral hip joints, collapsing of bilateral femoral heads, unsmooth femoral head articular surfaces with increasing density, quasi-circular and low-density shadows under the articular surface, unclear boundary, narrowing of joint space, and femoral neck shortening. Temporal bone CT scan and all the ophthalmic tests were normal.
The older sister (II2) of the proband was 28-years-old. She had a short stature with disproportionate short neck and trunk since she was a child. She was 143 cm tall and weighed 42 kg when she was taken examination. Midfacial dysplasia, bones and joints pain and unsteady waddling gait were also present. Hip joint X-ray revealed ischemia of femoral heads, hyperplasia and sharpened edges of femoral heads, unsmooth acetabular and femoral head articular surfaces with nonhomogeneous density, patchy and slightly low-density shadows, and narrowing of joint space. The PTA, temporal bone CT scan and all the ophthalmic tests were normal.
The nephew of the proband (III1) was a 3-years-old boy with normal hearing and speech development, while having growth retardation. He was 75 cm tall and weighed 8.5 kg when he was taken physical examination. Midfacial dysplasia, disproportionate short neck and trunk, and pigeon chest could be detected by visual examination. He had no noticeable bones or joints pain, and had no difficulty in walking. Due to his inability to cooperate, he did not undergo auxiliary examination including PTA, temporal bone CT scan and ophthalmic examinations.
The 20-years-old younger sister (II4) of the proband was 162 cm tall and weighed 55 kg. No abnormalities were found in the auditory, visual and skeletal systems.
All the family members were Li nationality and denied the history of ototoxic drug abuse and noise exposure. There was no consanguineous marriage in the family. All the family members had normal intelligence and normal birth history. Their birth weight and length had not been recorded. The adult patients in this family were taller than the average height for SEDC adult patients, which was regarded as 115.50 cm . The pain of bones and joints was progressively aggravated among the adult patients. All the family members’ bilateral tympanic membranes were clear by electro-otoscope examination. Other SEDC manifestations such as cleft palate, short-toe deformity and flattened vertebral bodies were not presented in the family patients (see Figs. 1 and 2).
Exons and adjacent intronic regions were captured and sequenced using WES for the patient II3 and I2. After the databases filtration and bioinformatics analyses on the data, a heterozygous variation c.1510G>A (p.Gly504Ser) in exon 23 of the COL2A1 gene (NM_001844.4) was detected. It was predicted to be the potential disease-causing variant of the Chinese Li nationality family. We didn’t find any known pathogenic deafness-related variants in mitochondrial genome of the family members. Sanger sequencing confirmed the co-segregation of the candidate COL2A1 variation with the phenotype in Family 1,908,322 (see Fig. 3).
Variation detection and analysis
The average sequencing depth and coverage for targeted region were satisfied with the requirements for calling SNPs and InDels (Additional File 1: Table S1). In the filtering process of variants of II3, firstly, using genotype frequency, including 1000 human genome dataset, ExAC, ESP6500, GnomAD and BGI in-house Database, less than 0.01 as the filtering criteria, 336 heterozygous mutations and 9 homozygous mutations were filtered out from the annotated variants (Additional File 1: Table S1–S3). Secondly, the annotations in databases were used to score the location and impact of mutations. There were 166 heterozygous and 2 homozygous functional variations including tran ablation/stop gained/stop lost/frameshift /missense/inframe insertion/deletion were filtered out. Thirdly, 52 heterozygous variants were predicted to be deleterious by software such as SIFT, MutationTaster, Polyphen2, Phylop, GERP et al. Among these variants, COL2A1 G504S was the only one which was associated with SEDC and hearing loss by checking for disease and gene-specific databases (see Additional File 2: Fig. S1 and Additional File 1: Table S2). The filtering analysis process of variants of I2 was similar to that of II3 (see Additional File 3: Fig. S2 and Additional File 1: Table S2). The variation had been reported to be the pathogenic variation of SEDC, regarded as a hot spot variation [4,5,6,7,8,9]. The genotype frequency in the 1000 Genomes Project, ESP and ExAC was less than 0.001. The population frequency in databases such as ESP6500, Thousands, EXAC, GnomAD was 0. The variant occurred within the highly evolutionarily conserved region across different species and was predicted to be deleterious with Condel, PolyPhen 2, Mutationtaster and SIFT programs (Additional file 1: Table 3). We ruled out other possible heterozygous, homozygous nor compound heterozygous variations by WES (Additional File 1: Table S4–S5). And all the family members didn’t carry any known deafness-related mitochondrial variants. We had found sufficient evidence (PS1 + PM1 + PM2 + PP2 + PP3 + PP1-Moderate + PP4 + PS4-Support) according to the American College of Medical Genetics and Genomics Guideline  to prove COL2A1 c.1510G>A to be the pathogenic variant of Family 1,908,322.
Hearing loss represents an infrequent manifestation of patients with SEDC. Only six mutations of COL2A1 gene had been reported to simultaneously cause hearing loss and scoliosis [4, 11,12,13,14,15] (Table 1). Hearing loss was absent in patients’ phenotypic spectrum caused by p.G504S of COL2A1 before this study (Table 2). In this family, the proband (II3) suffered from profound sensorineural hearing loss. Her mother (I2) had bilateral mild sensorineural hearing loss. There were considerable differences in the degree of their hearing loss. We did not find any possible deafness-causing variations except G504S in COL2A1 using WES and checking for mitochondrial genome. Other known genetic causes were ruled out and the patient had a normal birth and denied history of ototoxic drug abuse and noise exposure. In previous studies [4, 11,12,13,14,15], phenotypic diversity was prevalent in COL2A1-related diseases, especially SEDC combined with hearing impairment. Hearing loss varied from mild to profound (Table 1). Actually, the proband had more severe deformities and dysfunction in visual, auditory and skeletal systems than other patients within the family. To be more specific, myopia, ocular fundus changes, auditory ossicles dysplasia and deformity of elbow and wrist joints were only occurred in the proband. Moreover, the height of the proband was shorter. And her scoliosis and hip joints abnormality such as femoral heads disease were more pronounced than the corresponding phenotypes of patient I2 and II2. Therefore, the difference of hearing loss degree was more likely one of phenotypic spectrum diversity associated to the common genetic pathogenesis, which was identified to be the variant G504 in COL2A1. Possible reasons for phenotypic differences within the family include: (1) incomplete penetrance in this family (2) randomness in developmental processes such as gene expression.
The application and records of audiological tests were generally scarce in previous literatures [4, 11,12,13,14,15]. Hearing impairment descriptions were mostly based on the patients’ chief complaints rather than audiological examinations. The degrees of hearing loss varied from mild to profound and most patients were suffered from sensorineural hearing loss. In addition, Dahiya et al.  describe a case of a patient with mixed hearing loss that was likely attributable to stapes fixation. It was also believed that type II collagen was present in the cartilage that gave rise to the ossicles, which could account for the malformation of ossicles of the proband in the present study. Compared with SEDC, another subtype of COL2A1-related diseases type I of Stickler syndrome (STL1) had a much higher incidence of SNHL, from 50 to 75%. These STL1 patients suffered from mild-to-moderate high-frequencies SNHL since their childhood and their hearing loss progressed more slowly [16,17,18].
The mechanism for the auditory system abnormality associated with COL2A1 had not been fully uncovered. In humans, COL2A1 gene was expressed in cartilage cell, vitreous humor, intervertebral disc and inner ear structures. In the gerbil model, type II collagen in the connective tissue and tectorial membrane of the organ of Corti combined with radiating fibres to form a highly structured matrix together with type V and type IX collagen, which helped to enhance the hardness of tectorial membrane and enabled it to withstand the physical stress caused by sound conduction .
The mutation p.G504S of COL2A1 had been reported as the pathogenesis of 7 unrelated families before this study (see Table 2). The ethnicity of the patients was either Han Chinese or Japanese. The patients in this study were the Li ethnic group from Hainan Province, southern China. Besides hearing impairment, atypical manifestations in the proband, including auditory ossicles deformity, retinal detachment, midfacial dysplasia, thoracocyllosis, sacrum cracked and elbow and wrist joints deformity, had never been demonstrated in SEDC patients caused by mutation p.G504S. On the other hand, several manifestations, including disproportionate short stature and neck, spine malformation including scoliosis and kyphosis, acetabulum abnormal, and femoral head disease, were common symptoms among different families. The proband from Family 1  had a pain, limitation in hip mobility and abnormal gait from 5 years old and the symptoms increased with age. Short heights, lower extremities and spines abnormal were his main clinical manifestations. All affected individuals presented with similar clinical features in Family 3  rather than significant diversity in the Li nationality family in this study. In family 4 and family 5, the p.G504S was responsible for milder skeletal phenotypes, called subtypes SEDC-M (SEDC-mild) and SEDT (late-onset SED), than the phenotype in this study .
The COL2A1-related spectrum diseases demonstrate significant genetic heterogeneity. Despite numerous studies had been done, a clear and directional correlation between genotype and phenotype has not yet been established. Several speculations were made in the previous literatures. And a few specific genotype–phenotype relationships have been described. For example, splicing variations was considered to be more likely to cause severe hearing loss and patients with splicing variations had a higher proportion of hearing aid . Mutations located in the C-terminal (carboxyl terminal) propeptide of the type II procollagen could also cause hearing impairment. Terhal et al.  reported that half of 6 patients with a C-terminal propeptide variation complained of hearing loss, and one required hearing aids. Moreover, variations in the C-terminal domains seemed more likely to produce severe spinal deformity, coxa arthropathy, cleft palate and hearing impairment, because the collagen triple helix would fold in a C-to-N terminal direction . In the present study, the disease-causing variant was not in the C-terminal propeptide and the other five variations associated with SEDC and SNHL simultaneously were evenly distributed without the tendency of aggregation at C-terminal. It suggested that other mechanisms may be existed to contribute to hearing loss. The Gly-X-Y amino acid combination is considered to be one of the most significant peptide chain domains in the occurrence of COL2A1-related diseases. A glycine (Gly) appears for every three amino acid residues on the α1 chain. The structure composed of 330 Gly-X-Y repeats has the ability to bind receptors and other functional proteins, which is essential for the structural stability of type II collagen. Variations on the Gly-X-Y repeats would damage the triple-helical conformation and impair the intracellular transport of collagen, thus leading to over-modification of collagen and destruction of long bone development . Corresponding to the enrichment of Gly-X-Y repeat in the COL2A1 protein, glycine substitutions constitute the predominant part of the COL2A1 gene variation spectrum (305 of 405 variations till 2016) . Before this study, all the six variations causing SEDC accompanied with SNHL were glycine substitutions. Glycine to serine substitutions, unlike glycine to nonserine residue substitutions, caused variable phenotypes [4, 23]. Some glycine to serine substitutions produced severe skeletal phenotypes, while others exclusively created mild skeletal phenotypes. In this study, the disease-causing variation was glycine to serine substitution and different individuals differ in the severity of spine and hip joint diseases, which was consistent with the feature of glycine-serine substitution.
In conclusion, the hot mutation p.G504S in COL2A1 gene was identified as the pathogenesis in this Chinese Li nationality family. It was the first report to find the correlation between p.G504S and atypical clinical phenotypes including sensorineural hearing loss, auditory ossicles deformity, retinal detachment, sacrum cracked and elbow and wrist joints deformity. Our findings would extend the phenotypic spectrum of SEDC and deepen clinicians' understanding of genotype–phenotype correlation of the disease.
Availability of data and materials
The sequencing data used and/or analyzed during the current study are available at the following URL: https://www.ncbi.nlm.nih.gov/bioproject/739493 or in the BioProject database under accession number PRJNA739493.
Spondyloepiphyseal dysplasia congenital
Sensorineural hearing loss
Whole exome sequencing
Deng H, Huang X, Yuan L. Molecular genetics of the COL2A1-related disorders. Mutat Res Rev Mutat Res. 2016;768:1–13.
Dahiya R, Cleveland S, Megerian CA. Spondyloepiphyseal dysplasia congenita associated with conductive hearing loss. Ear Nose Throat J. 2000;79(3):178–82.
Jung SC, Mathew S, Li QW, et al. Spondyloepiphyseal dysplasia congenita with absent femoral head. J Pediatr Orthop B. 2004;13(2):63–9.
Nishimura G, Haga N, Kitoh H, et al. The phenotypic spectrum of COL2A1 mutations. Hum Mutat. 2005;26(1):36–43.
Xia X, Cui Y, Huang Y, et al. A first familial G504S mutation of COL2A1 gene results in distinctive spondyloepiphyseal dysplasia congenita. Int J Clin Chem. 2007;382:148–50.
Cao LH, Wang L, Ji CY, et al. Novel and recurrent COL2A1 mutations in Chinese patients with spondyloepiphyseal dysplasia. Genet Mol Res: GMR. 2012;11(4):4130–7.
Kawano O, Nakamura A, Morikawa S, et al. Spondyloepiphyseal dysplasia congenita caused by double heterozygous mutations in COL2A1. Am J Med Genet A. 2015;167(7):1578–81.
Zhang H, Yang R, Wang Y, et al. A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing. J Hum Genet. 2015;60(12):769–76.
Xu Y, Li L, Wang C, et al. Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia. Int J Biol Sci. 2020;16(5):859–68.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
Sobetzko D, Eich G, Kalff-Suske M, et al. Boy with syndactylies, macrocephaly, and severe skeletal dysplasia: not a new syndrome, but two dominant mutations (GLI3 E543X and COL2A1 G973R) in the same individual. Am J Med Genet. 2000;90(3):239–42.
Zhang Z, He JW, Fu WZ, et al. Identification of three novel mutations in the COL2A1 gene in four unrelated Chinese families with spondyloepiphyseal dysplasia congenita. Biochem Biophys Res Commun. 2011;413(4):504–8.
Xu L, Qiu X, Zhu Z, et al. A novel mutation in COL2A1 leading to spondyloepiphyseal dysplasia congenita in a three-generation family. Eur Spine J. 2014;23(Suppl 2):271–7.
Zheng WB, Li LJ, Zhao DC, et al. Novel variants in COL2A1 causing rare spondyloepiphyseal dysplasia congenita. Mol Genet Genomic Med. 2020;8(3):e1139.
Ideura M, Nishio SY, Moteki H, et al. Comprehensive analysis of syndromic hearing loss patients in Japan. Sci Rep. 2019;9(1):11976.
Rose PS, Levy HP, Liberfarb RM, et al. Stickler syndrome: clinical characteristics and diagnostic criteria. Am J Med Genet A. 2005;3:199–207.
Acke FR, Swinnen FK, Malfait F, et al. Auditory phenotype in Stickler syndrome: results of audiometric analysis in 20 patients. Eur Arch Otorhinolaryngol. 2016;273(10):3025–34.
Szymko-Bennett YM, Mastroianni MA, Shotland LI, et al. Auditory dysfunction in Stickler syndrome. Arch Otolaryngol Head Neck Surg. 2001;127(9):1061–8.
Slepecky NB, Savage JE, Yoo TJ. Localization of type II, IX and V collagen in the inner ear. Acta Otolaryngol. 1992;112(4):611–7.
Walter K, Tansek M, Tobias ES, et al. COL2A1-related skeletal dysplasias with predominant metaphyseal involvement. Am J Med Genet A. 2007;2:161–7.
Terhal PA, Nievelstein RJ, Verver EJ, et al. A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. Am J Med Genet A. 2015;167a(3):461–75.
Liu L, Pang Q, Jiang Y, et al. Novel COL2A1 mutations causing spondyloepiphyseal dysplasia congenita in three unrelated Chinese families. Eur Spine J. 2016;25(9):2967–74.
Mortier GR, Weis M, Nuytinck L, et al. Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet. 2000;37(4):263–71.
We appreciate the cooperation of the patients and their family members during this work. We also thank the technicians in the Clinical Auditory Medicine Centre at the Department of Otolaryngology Head and Neck Surgery, the Hainan branch of Chinese PLA General Hospital for their technical supports.
This work was supported by the grants of the National Natural Science Foundation of China (81600814); Military Medical Personnel Support Foundation of Air Force Medical University (granted to Wang XC).
Consent for publication
Written informed consents for publication from all the participants in the family were obtained from the next of kin on the behalf of the minors/children participants involved in this study.
Ethics approval and consent to participate
The study was approved by the Committee of Medical Ethics of Chinese PLA General Hospital. Written informed consent from all the participants in the family was obtained. All the experiments were performed in accordance with the Declaration of Helsinki and other relevant guidelines and regulations.
All the authors declare that there is no conflict of interest regarding the publication of this paper.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
. Supplementary tables. Supplementary Table 1. The whole-exome sequencing parameters of the two patients. Supplementary Table 2. Filtration process for heterozygous variants. Supplementary Table 3. Variant pathogenicity analysis.
Filtering flow of variants of patient II3.
. Filtering flow of variants of patient I2.
About this article
Cite this article
Wu, K., Li, Z., Zhu, Y. et al. Discovery of sensorineural hearing loss and ossicle deformity in a Chinese Li nationality family with spondyloepiphyseal dysplasia congenita caused by p.G504S mutation of COL2A1. BMC Med Genomics 14, 170 (2021). https://doi.org/10.1186/s12920-021-01020-y
- Spondyloepiphyseal dysplasia congenita
- Sensorineural hearing loss